Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Multiple Sclerosis

  Free Subscription


Articles published in Neurologia

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    March 2021
  1. ALONSO-MORENO M, Ladron-Guevara M, Ciudad-Gutierrez P
    Systematic review of gender bias in clinical trials of monoclonal antibodies for the treatment of multiple sclerosis.
    Neurologia. 2021 Mar 25. pii: S0213-4853(21)00008.
    PubMed     Abstract available


  2. LOPEZ-GOMEZ J, Sacristan-Enciso B, Caro-Miro MA
    Clinically isolated syndrome: diagnosis and risk of developing clinically definite multiple sclerosis.
    Neurologia. 2021 Mar 20. pii: S0213-4853(21)00028.
    PubMed     Abstract available


  3. LLUFRIU S, Aguera E, Costa-Frossard L, Galan V, et al
    Recommendations for the coordination of Neurology and Neuroradiology Departments in the management of patients with multiple sclerosis.
    Neurologia. 2021 Mar 17. pii: S0213-4853(21)00029.
    PubMed     Abstract available


  4. ALBA SUAREZ EM, Tallon Barranco A, Puertas Munoz I, Chamorro Hernandez B, et al
    Non-late-onset neutropaenia following treatment of multiple sclerosis with ocrelizumab.
    Neurologia. 2021 Mar 13. pii: S0213-4853(21)00026.
    PubMed     Abstract available


  5. SANCHEZ-SOBLECHERO A, Cuello JP, Martinez Gines ML, Lozano Ros A, et al
    Recurrent intracranial hemorrhage in a patient with relapsing multiple sclerosis under interferon-beta therapy.
    Neurologia. 2021 Mar 12. pii: S0213-4853(21)00011.
    PubMed    


    February 2021
  6. VAZQUEZ-MARRUFO M, Sarrias-Arrabal E, Garcia-Torres M, Martin-Clemente R, et al
    A systematic review of the application of machine-learning algorithms in multiple sclerosis.
    Neurologia. 2021 Feb 3. pii: S0213-4853(20)30431.
    PubMed     Abstract available


    October 2020
  7. ZHANG G, Carrillo-Vico A, Zhang W, Gao SS, et al
    Incidence and prevalence of multiple sclerosis in China and other Asian countries.
    Neurologia. 2020 Oct 14. pii: S0213-4853(20)30269.
    PubMed     Abstract available


    September 2020
  8. OSTOLAZA IBANEZ A, Corroza Lavineta J, Ayuso Blanco T
    Immunosenescence: the role of age in multiple sclerosis.
    Neurologia. 2020 Sep 19. pii: S0213-4853(20)30226.
    PubMed     Abstract available


  9. GAVIRIA CARRILLO M, Ortiz Salas PA, Rueda Vergara KP, Cortes Bernal GA, et al
    Tools for comprehensive evaluation of sexual function in patients with multiple sclerosis.
    Neurologia. 2020 Sep 8. pii: S0213-4853(20)30220.
    PubMed     Abstract available


  10. VALERO-LOPEZ G, Carreon-Guarnizo E, Hernandez-Clares R, Iniesta-Martinez F, et al
    Erratum to "Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm" [Neurologia. 2020;35(6):357-362].
    Neurologia. 2020;35:541.
    PubMed    


    August 2020
  11. ZHANG GX, Sanabria C, Martinez D, Zhang WT, et al
    Socio-labor consequences of confinement by COVID-19 in patients with multiple sclerosis in two very different populations.
    Neurologia. 2020 Aug 13. pii: S0213-4853(20)30264.
    PubMed     Abstract available


    July 2020
  12. RIVERA VM, Gracia F, Diaz A
    Therapeutic attitudes towards multiple sclerosis in Central America and the Caribbean facing the SARS-CoV-2 pandemia.
    Neurologia. 2020 Jul 28. pii: S0213-4853(20)30237.
    PubMed    


    June 2020
  13. GOMEZ IGLESIAS P, Sanesteban Beceiro E, Gomez Ruiz MN, Matias Guiu JA, et al
    Half and half syndrome as a presentation of multiple sclerosis.
    Neurologia. 2020 Jun 22. pii: S0213-4853(20)30130.
    PubMed    


  14. OTERO-ROMERO S, Rodriguez-Garcia J, Vilella A, Ara JR, et al
    Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.
    Neurologia. 2020 Jun 17. pii: S0213-4853(20)30045.
    PubMed     Abstract available


  15. GARCIA ESTEVEZ DA
    25(Oh)D3 deficit and multiple sclerosis: A simple epidemiological association or a true causal relationship.
    Neurologia. 2020 Jun 14. pii: S0213-4853(20)30118.
    PubMed    


  16. VALERO-LOPEZ G, Carreon-Guarnizo E, Hernandez-Clares R, Iniesta-Martinez F, et al
    Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm.
    Neurologia. 2020 Jun 8. pii: S0213-4853(20)30138.
    PubMed     Abstract available


    January 2020
  17. GOMEZ-MORENO SM, Cuadrado ML, Cruz-Orduna I, Martinez-Acebes EM, et al
    Validation of the Spanish-language version of the Montreal Cognitive Assessment as a screening test for cognitive impairment in multiple sclerosis.
    Neurologia. 2020 Jan 23. pii: S0213-4853(19)30149.
    PubMed     Abstract available


  18. TORRE-FUENTES L, Moreno-Jimenez L, Pytel V, Matias-Guiu JA, et al
    Experimental models of demyelination and remyelination.
    Neurologia. 2020;35:32-39.
    PubMed     Abstract available


    May 2019
  19. MENDIBE BILBAO M, Boyero Duran S, Barcena Llona J, Rodriguez-Antiguedad A, et al
    Multiple sclerosis: Pregnancy and women's health issues.
    Neurologia. 2019;34:259-269.
    PubMed     Abstract available


    April 2019
  20. LEBRATO HERNANDEZ L, Prieto Leon M, Cerda Fuentes NA, Ucles Sanchez AJ, et al
    Restless legs syndrome in patients with multiple sclerosis: evaluation of risk factors and clinical impact.
    Neurologia. 2019 Apr 5. pii: S0213-4853(19)30030.
    PubMed     Abstract available


  21. CIFUENTES-CANOREA P, Nieves-Moreno M, Saenz-Frances F, Santos-Bueso E, et al
    Early and recurrent macular oedema in a patient treated with fingolimod.
    Neurologia. 2019;34:206-207.
    PubMed    


    October 2018
  22. CASTILLO-BUENO I, Ramos-Campo DJ, Rubio-Arias JA
    Effects of whole-body vibration training in patients with multiple sclerosis: A systematic review.
    Neurologia. 2018;33:534-548.
    PubMed     Abstract available


    June 2018
  23. EICHAU S, Lopez Ruiz R, Caston Osorio JJ, Ramirez E, et al
    Primary cytomegalovirus infection in a patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab.
    Neurologia. 2018 Jun 12. pii: S0213-4853(18)30118.
    PubMed    


  24. LEON RUIZ M, Sospedra M, Arce Arce S, Tejeiro-Martinez J, et al
    Current evidence on the potential therapeutic applications of transcranial magnetic stimulation in multiple sclerosis: A systematic review of the literature.
    Neurologia. 2018 Jun 10. pii: S0213-4853(18)30153.
    PubMed     Abstract available


  25. CASTILLO-ALVAREZ F, Perez-Matute P, Oteo JA, Marzo-Sola ME, et al
    The influence of interferon beta-1b on gut microbiota composition in patients with multiple sclerosis.
    Neurologia. 2018 Jun 9. pii: S0213-4853(18)30158.
    PubMed     Abstract available


  26. PEREZ-ALVAREZ AI, Suarez-Santos P, Gonzalez-Delgado M, Oliva-Nacarino P, et al
    Quantification of brain atrophy in multiple sclerosis using two-dimensional measurements.
    Neurologia. 2018 Jun 8. pii: S0213-4853(18)30152.
    PubMed    


  27. LEON RUIZ M, Mitchell AJ, Benito-Leon J
    Delusional parasitosis in multiple sclerosis: An enigmatic manifestation of a multifaceted disease.
    Neurologia. 2018 Jun 8. pii: S0213-4853(18)30116.
    PubMed    


  28. RAMIO-TORRENTA L, Alvarez-Cermeno JC, Arroyo R, Casanova-Estruch B, et al
    A guide to treating gait impairment with prolonged-release fampridine (Fampyra((R))) in patients with multiple sclerosis.
    Neurologia. 2018;33:327-337.
    PubMed     Abstract available


    May 2018
  29. RODRIGUEZ DE ANTONIO LA, Garcia Castanon I, Aguilar-Amat Prior MJ, Puertas I, et al
    Non-inflammatory causes of emergency consultation in patients with multiple sclerosis.
    Neurologia. 2018 May 26. pii: S0213-4853(18)30095.
    PubMed     Abstract available


  30. PATO PATO A, Costa Arpin E, Rodriguez Regal A, Rodriguez Constenla I, et al
    Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the "no evidence of disease activity" parameter.
    Neurologia. 2018 May 10. pii: S0213-4853(18)30083.
    PubMed     Abstract available


  31. HOCHSPRUNG A, Escudero-Uribe S, Ibanez-Vera AJ, Izquierdo-Ayuso G, et al
    Effectiveness of monopolar dielectric transmission of pulsed electromagnetic fields for multiple sclerosis-related pain: A pilot study.
    Neurologia. 2018 May 8. pii: S0213-4853(18)30088.
    PubMed     Abstract available


    April 2018
  32. MATIAS-GUIU J, Oreja-Guevara C, Matias-Guiu JA, Gomez-Pinedo U, et al
    Vitamin D and remyelination in multiple sclerosis.
    Neurologia. 2018;33:177-186.
    PubMed     Abstract available


    March 2018
  33. PEREZ SANCHEZ S, Eichau Madueno S, Rus Hidalgo M, Dominguez Mayoral AM, et al
    Usefulness of optic nerve ultrasound to predict clinical progression in multiple sclerosis.
    Neurologia. 2018 Mar 21. pii: S0213-4853(18)30026.
    PubMed     Abstract available


  34. RAMOS GONZALEZ EJ, Ramirez Jirano LJ, Garcia Martinez DZ, Ortiz GG, et al
    A comparative study of melatonin and immunomodulatory therapy with interferon beta and glatiramer acetate in a mouse model of multiple sclerosis.
    Neurologia. 2018 Mar 8. pii: S0213-4853(18)30022.
    PubMed     Abstract available


  35. PARRA-MORENO M, Rodriguez-Juan JJ, Ruiz-Cardenas JD
    Use of commercial video games to improve postural balance in patients with multiple sclerosis: A systematic review and meta-analysis of randomised controlled clinical trials.
    Neurologia. 2018 Mar 7. pii: S0213-4853(18)30010.
    PubMed     Abstract available


    January 2018
  36. ALVAREZ AYUSO L, Rodriguez Marrodan B, Blasco Quilez MR, Garcia-Merino JA, et al
    Economic impact of the new oral treatments for multiple sclerosis.
    Neurologia. 2018 Jan 11. pii: S0213-4853(17)30375.
    PubMed     Abstract available


    September 2017
  37. GUERRERO-GARCIA JJ
    The role of astrocytes in multiple sclerosis pathogenesis.
    Neurologia. 2017 Sep 25. pii: S0213-4853(17)30281.
    PubMed     Abstract available


  38. HOCHSPRUNG A, Granja Dominguez A, Magni E, Escudero Uribe S, et al
    Effect of visual biofeedback cycling training on gait in patients with multiple sclerosis.
    Neurologia. 2017 Sep 6. pii: S0213-4853(17)30251.
    PubMed     Abstract available


    May 2017
  39. HERNANDEZ CLARES R, Sanchez Pedreno P, Garcia Vazquez E, Carreon Guarnizo E, et al
    Aggressive cutaneous leishmaniasis in a patient with multiple sclerosis treated with fingolimod.
    Neurologia. 2017 May 20. pii: S0213-4853(17)30138.
    PubMed    


    April 2017
  40. MARTINEZ-GINES ML, Garcia-Dominguez JM, Sarmiento M, Maurino J, et al
    Spanish cultural adaptation of the short version of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23).
    Neurologia. 2017 Apr 5. pii: S0213-4853(17)30105.
    PubMed    


    March 2017
  41. GONZALEZ GOMEZ A, Garcia-Ben A, Soler Garcia A, Garcia-Basterra I, et al
    Longitudinal study of visual function in patients with relapsing-remitting multiple sclerosis with and without a history of optic neuritis.
    Neurologia. 2017 Mar 15. pii: S0213-4853(17)30024.
    PubMed     Abstract available


  42. CUELLO JP, Martinez Gines ML, Martin Barriga ML, de Andres C, et al
    Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
    Neurologia. 2017;32:92-98.
    PubMed     Abstract available


    January 2017
  43. MUNTEIS OLIVAS E, Navarro Mascarell G, Meca Lallana J, Maestre Martinez A, et al
    Cultural adaptation and validation of a peninsular Spanish version of the MSTCQ(c) (Multiple Sclerosis Treatment Concerns Questionnaire).
    Neurologia. 2017;32:29-39.
    PubMed     Abstract available


    October 2016
  44. GILI-MINER M, Lopez-Mendez J, Vilches-Arenas A, Ramirez-Ramirez G, et al
    Multiple sclerosis and alcohol use disorders: In-hospital mortality, extended hospital stays, and overexpenditures.
    Neurologia. 2016 Oct 22. pii: S0213-4853(16)30173.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: